Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Fürnau

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 7, 2022
[Mechanical Assist Devices in Cardiogenic Shock Complicating Myocardial Infarction]Carlo-Federico Fichera, Georg Fürnau
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Tools & techniques: Percutaneous left ventricular assist devicesHolger Thiele, Georg Fürnau, Julia Fischer, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2016
Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trialUwe Zeymer, Karl Werdan, Gerhard Schuler, et al.
Circulation|June 19, 2008
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trialHolger Thiele, Kathrin Schindler, Josef Friedenberger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 22, 2011
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarctionSteffen Desch, Annelie Siegemund, Ute Scholz, et al.
International Journal of Cardiology|October 9, 2025
Insulin-like growth factor binding protein 2 (IGFBP-2) as prognostic parameter in infarct-related cardiogenic shockMaryna Masyuk, Bernhard Wernly, Malte Kelm, et al.
American Heart Journal|April 10, 2025
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trialHans-Josef Feistritzer, Alexander Jobs, Uwe Zeymer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|September 7, 2022
[Mechanical Assist Devices in Cardiogenic Shock Complicating Myocardial Infarction]Carlo-Federico Fichera, Georg Fürnau
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Tools & techniques: Percutaneous left ventricular assist devicesHolger Thiele, Georg Fürnau, Julia Fischer, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2016
Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trialUwe Zeymer, Karl Werdan, Gerhard Schuler, et al.
Circulation|June 19, 2008
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trialHolger Thiele, Kathrin Schindler, Josef Friedenberger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 22, 2011
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarctionSteffen Desch, Annelie Siegemund, Ute Scholz, et al.
International Journal of Cardiology|October 9, 2025
Insulin-like growth factor binding protein 2 (IGFBP-2) as prognostic parameter in infarct-related cardiogenic shockMaryna Masyuk, Bernhard Wernly, Malte Kelm, et al.
American Heart Journal|April 10, 2025
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trialHans-Josef Feistritzer, Alexander Jobs, Uwe Zeymer, et al.
Pageof 1